Download PDF
1 / Pages

Other users also viewed these articles

Gadolinium-enhanced brain lesions in multiple sclerosis relapse L. Martín-Aguilar; S. Presas-Rodriguez; À. Rovira; J. Capellades; A. Massuet-Vilamajó; L. Ramió-Torrentà; M. Tintoré; L. Brieva-Ruiz; E. Moral; A. Cano-Orgaz; Y. Blanco; J. Batlle-Nadal; O. Carmona; M. Gea; J.V. Hervás-García; C. Ramo-Tello;
Neurologia. 2022;37:557-63
Progression of a series of patients with relapsing-remitting multiple sclerosis treated for 7 years with natalizumab using the ¿no evidence of disease activity¿ parameter A. Pato Pato; E. Costa Arpín; A. Rodríguez Regal; I. Rodríguez Constenla; I. Cimas Hernando; I. Muñoz Pousa; L. Naya Ríos; J.R. Lorenzo González; M.C. Amigo Jorrín; J.M. Prieto González;
Neurologia. 2021;36:346-52